We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BXSL:NYSEBlackstone Secured Lending Fund Analysis

Data as of 2026-05-22 - not real-time

$23.33

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Blackstone Secured Lending Fund (BXSL) trades at $23.33, well below its 20‑day ($24.06) and 50‑day ($23.98) moving averages and the 200‑day SMA of $26.12, suggesting a pricing discount. PE of 12.2 versus the industry average of 16.8 and a price‑to‑book of 0.89 reinforce an undervalued valuation, while the upside potential of roughly 7.5% aligns with analyst target prices around $25.1‑$25.25. The fund delivers an eye‑catching 13% dividend yield, but a payout ratio of 161% and a recent jump in non‑accrual loans to 3.1% raise questions about dividend sustainability. Q1 2026 net investment income of $0.77 per share covered the quarterly dividend, yet operating cash flow remains negative at -$634 M, highlighting cash‑generation pressure. Leverage is substantial, with total debt of $8.03 B and a debt‑to‑equity ratio of 132, which amplifies credit and liquidity risk. Technical indicators are mixed: RSI at 40.7 signals neutral momentum, while a bearish MACD and decreasing volume suggest short‑term weakness. The fund’s beta of 0.53 indicates lower market volatility, but a 30‑day volatility of 23% points to price swings. Analyst sentiment is positive (Buy, Outperform) with a median target of $25.25, reflecting confidence in the underlying loan portfolio’s resilience amid market turbulence. Overall, BXSL offers attractive income at a discount, but investors must weigh high leverage and dividend coverage concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near key support at $23.27
  • Bearish MACD and decreasing volume
  • High dividend yield but sustainability concerns

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation upside to analyst target ~ $25.2
  • Q1 earnings covered dividend and show portfolio resilience
  • PE and P/B below industry averages

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Elevated leverage and debt‑to‑equity ratio
  • Uncertain dividend sustainability with high payout ratio
  • Stable sector fundamentals and low beta

Key Metrics & Analysis

Financial Health

Revenue Growth-9.00%
Profit Margin31.65%
P/E Ratio12.2
ROE7.11%
ROA4.99%
Debt/Equity131.71
P/B Ratio0.9
Op. Cash Flow$-634064000
Free Cash Flow$367.4M
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI40.7
Support$23.27
Resistance$25.29
MA 20$24.06
MA 50$23.98
MA 200$26.12
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Target Price$25.10
Upside/Downside7.59%
GradeUndervalued
TypeBlend
Dividend Yield13.08%

Risk Assessment

Beta0.53
Volatility23.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.